×
About 5,643 results

ALLMedicine™ Anthrax Center

Research & Reviews  2,019 results

Modeling the Potential Future Distribution of Anthrax Outbreaks under Multiple Climate ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103515
International Journal of Environmental Research and Publi... Otieno FT, Gachohi J et. al.

Apr 30th, 2021 - The climate is changing, and such changes are projected to cause global increase in the prevalence and geographic ranges of infectious diseases such as anthrax. There is limited knowledge in the tropics with regards to expected impacts of climate ...

A whole genome-based gene-by-gene typing system for standardised high resolution strain...
https://doi.org/10.1128/JCM.02889-20
Journal of Clinical Microbiology; Abdel-Glil MY, Chiaverini A et. al.

Apr 8th, 2021 - Whole-genome-sequencing (WGS) has been established for bacterial subtyping and is regularly used to study pathogen transmission, to investigate outbreaks, and to perform routine surveillance. Core genome multilocus sequence typing (cgMLST) is a ba...

Modeling the spatial distribution of anthrax in southern Kenya.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032196
PLoS Neglected Tropical Diseases; Otieno FT, Gachohi J et. al.

Mar 29th, 2021 - Anthrax is an important zoonotic disease in Kenya associated with high animal and public health burden and widespread socio-economic impacts. The disease occurs in sporadic outbreaks that involve livestock, wildlife, and humans, but knowledge on f...

Bacillus anthracis chain length, a virulence determinant, is regulated by membrane loca...
https://doi.org/10.1128/JB.00582-20
Journal of Bacteriology; Dhasmana N, Kumar N et. al.

Mar 23rd, 2021 - Anthrax is a zoonotic disease caused by Bacillus anthracis, a spore-forming pathogen that displays a chaining phenotype. It has been reported that the chaining phenotype acts as a virulence factor in B. anthracis In this study, we identify a serin...

High Case-Fatality Rate for Human Anthrax, Northern Ghana, 2005-2016.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007318
Emerging Infectious Diseases; Blackburn JK, Kenu E et. al.

Mar 23rd, 2021 - The human cutaneous anthrax case-fatality rate is ≈1% when treated, 5%-20% when untreated. We report high case-fatality rates (median 35.0%; 95% CI 21.1%-66.7%) during 2005-2016 linked to livestock handling in northern Ghana, where veterinary reso...

see more →

Guidelines  4 results

Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918956
MMWR. Recommendations and Reports : Morbidity and Mortali... Bower WA, Schiffer J et. al.

Dec 13th, 2019 - This report updates the 2009 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding use of anthrax vaccine in the United States (Wright JG, Quinn CP, Shadomy S, Messonnier N. Use of anthrax vaccine in the United...

Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incid...
https://doi.org/10.15585/mmwr.rr6404a1
MMWR. Recommendations and Reports : Morbidity and Mortali... Bower WA, Hendricks K et. al.

Dec 3rd, 2015 - In 2014, CDC published updated guidelines for the prevention and treatment of anthrax (Hendricks KA, Wright ME, Shadomy SV, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. E...

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee ...
https://www.ncbi.nlm.nih.gov/pubmed/20651644
MMWR. Recommendations and Reports : Morbidity and Mortali... Wright JG, Quinn CP et. al.

Jul 23rd, 2010 - These recommendations from the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations for anthrax vaccine adsorbed (AVA) (CDC. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee ...

Guidelines for Acquisition of Ventilators to Meet Demands for Pandemic Flu and Mass Casualty...
https://www.aarc.org/wp-content/uploads/2017/03/Issue-Paper-Acquisition-ventilators_pandemic.pdf
American Association for Respiratory Care (AARC)

Jan 29th, 2008 - Following the tragedy of September 11, 2001 and the anthrax mailings of the same year, the U. S.

see more →

Drugs  501 results see all →

Clinicaltrials.gov  2,799 results

Ciprofloxacin - ciprofloxacin tablet, film coated-Major Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62cb8a94-05a3-48e4-9b51-4ff0e2a72f10

May 2nd, 2021 - Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: • Skin and Skin Structure...

Modeling the Potential Future Distribution of Anthrax Outbreaks under Multiple Climate ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103515
International Journal of Environmental Research and Publi... Otieno FT, Gachohi J et. al.

Apr 30th, 2021 - The climate is changing, and such changes are projected to cause global increase in the prevalence and geographic ranges of infectious diseases such as anthrax. There is limited knowledge in the tropics with regards to expected impacts of climate ...

Ciprofloxacin - ciprofloxacin tablet-American Health Packaging
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4be79d58-1436-44c2-9b3a-836c6e4f1c67

Apr 29th, 2021 - Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections...

Levofloxacin - levofloxacin tablet, film coated-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a4e97e0-0709-411b-92e8-6f7d669412e4

Apr 25th, 2021 - Levofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated (1, 12.4). • Pneumonia: Nosocomial (1.1) and Commu...

Ciprofloxacin - ciprofloxacin tablet-DRUG OCEAN LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2457520c-ff99-415b-a640-83bae2aa4586

Apr 25th, 2021 - Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections...

see more →

News  301 results

The Week That Wasn't: Healing Honey, Restored Limb Function, Anti-Cancer Anthrax
https://www.medscape.com/viewarticle/922271

Dec 5th, 2019 - This week the internet was abuzz with tales of honey's healing power, a new solution for spinal cord injuries, and using anthrax against cancer. Here's why you didn't see those headlines on Medscape. Honey's Healing Power? It's feasible to use Man...

Anthrax booster expanded to 3 years for moderate-risk groups
https://www.mdedge.com/familymedicine/article/195362/vaccines/anthrax-booster-expanded-3-years-moderate-risk-groups?channel=39313
MDedge Infectious Disease; Heidi Splete

Feb 28th, 2019 - A booster dose for pre-exposure prophylaxis with an anthrax vaccine may be given at 3 years after an initial series for individuals not currently at risk who wish to maintain protection, according to the Centers for Disease Control and Prevention’.

see more →

Patient Education  19 results see all →